Lixia Zhang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Advances in Janus kinase inhibitors for vitiligo.
Journal: Frontiers in immunology
Published: April 29, 2026
Efficacy and safety of dupilumab following discontinuation of JAK inhibitors in patients with moderate-to-severe atopic dermatitis: a single-center retrospective study.
Journal: Frontiers in immunology
Published: March 29, 2026
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: July 25, 2025
Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trial.
Journal: Journal of the American Academy of Dermatology
Published: July 08, 2025
Dupilumab relieves pruritus both in uremic pruritus and in atopic dermatitis with chronic kidney disease: a retrospective real-world study.
Journal: Frontiers in medicine
Published: May 13, 2025
Recurrence and influencing factors of moderate-to-severe atopic dermatitis after dupilumab withdrawal: a retrospective cohort analysis.
Journal: Frontiers in medicine
Published: February 28, 2025
Efficacy and Safety of Dupilumab in Treating Intrinsic and Extrinsic Atopic Dermatitis in Older Patients With and Without Atopic Comorbidities: A Retrospective Study.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: February 12, 2025
Rapid improvement in a recurrent generalized pustular psoriasis patient ineffective to Ixekizumab following Spesolimab therapy.
Journal: Anais brasileiros de dermatologia
Published: July 30, 2024
Clinical features of von Zumbusch type of generalized pustular psoriasis in children: a retrospective study of 26 patients in southwestern China.
Journal: Anais brasileiros de dermatologia
Published: January 01, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026